Boston Children's Hospital, Department of Anesthesiology, Critical Care and Pain Medicine, Boston, Mass; Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass; Department of Anesthesia, Harvard Medical School, Boston.
Nationwide Children's Hospital, Division of Critical Care Medicine, Department of Pediatrics, Columbus, Ohio.
J Allergy Clin Immunol. 2020 Jun;145(6):1673-1680.e11. doi: 10.1016/j.jaci.2020.01.040. Epub 2020 Feb 6.
Decreased TNF-α production in whole blood after ex vivo LPS stimulation indicates suppression of the Toll-like receptor (TLR)4 pathway. This is associated with increased mortality in pediatric influenza critical illness. Whether antiviral immune signaling pathways are also suppressed in these patients is unclear.
We sought to evaluate suppression of the TLR4 and the antiviral retinoic acid-inducible gene-I (RIG-I) pathways with clinical outcomes in children with severe influenza infection.
In this 24-center, prospective, observational cohort study of children with confirmed influenza infection, blood was collected within 72 hours of intensive care unit admission. Ex vivo whole blood stimulations were performed with matched controls using the viral ligand polyinosinic-polycytidylic acid-low-molecular-weight/LyoVec and LPS to evaluate IFN-α and TNF-α production capacities (RIG-I and TLR4 pathways, respectively).
Suppression of either IFN-α or TNF-α production capacity was associated with longer duration of mechanical ventilation and hospitalization, and increased organ dysfunction. Children with suppression of both RIG-I and TLR4 pathways (n = 33 of 103 [32%]) were more likely to have prolonged (≥7 days) multiple-organ dysfunction syndrome (30.3% vs 8.6%; P = .004) or prolonged hypoxemic respiratory failure (39.4% vs 11.4%; P = .001) compared with those with single- or no pathway suppression.
Suppression of both RIG-I and TLR4 signaling pathways, essential for respective antiviral and antibacterial responses, is common in previously immunocompetent children with influenza-related critical illness and is associated with bacterial coinfection and adverse outcomes. Prospective testing of both pathways may aid in risk-stratification and in immune monitoring.
全血在体外 LPS 刺激后 TNF-α 产生减少表明 Toll 样受体(TLR)4 途径受到抑制。这与儿科流感危重病患者的死亡率增加有关。这些患者的抗病毒免疫信号通路是否也受到抑制尚不清楚。
我们旨在评估 TLR4 和抗病毒视黄酸诱导基因-I(RIG-I)途径在严重流感感染患儿中的抑制作用与临床结局的关系。
在这项针对确诊流感感染患儿的 24 中心前瞻性观察队列研究中,在入住重症监护病房的 72 小时内采集血液。使用匹配的对照物,通过病毒配体聚肌胞苷酸低分子量/LyoVec 和 LPS 对全血进行体外刺激,以评估 IFN-α 和 TNF-α的产生能力(分别代表 RIG-I 和 TLR4 途径)。
IFN-α或 TNF-α产生能力的抑制与机械通气和住院时间延长以及器官功能障碍增加有关。抑制 RIG-I 和 TLR4 途径的患儿(103 例患儿中有 33 例[32%])更有可能出现长时间(≥7 天)多器官功能障碍综合征(30.3%比 8.6%;P=0.004)或长时间低氧性呼吸衰竭(39.4%比 11.4%;P=0.001),而不是单一途径或无途径抑制。
两种信号通路(RIG-I 和 TLR4)的抑制,对各自的抗病毒和抗细菌反应至关重要,在先前免疫功能正常的流感相关危重病患儿中很常见,与细菌合并感染和不良结局有关。对这两种途径的前瞻性检测可能有助于风险分层和免疫监测。